期刊文献+

异构前列腺素在慢性心力衰竭发病中的作用

Effect of Isoprostanes on Chronic Heart Failure
下载PDF
导出
摘要 异构前列腺素是自由基催化,花生四烯酸的过氧化产物,在细胞膜上被磷脂酶释放,在血浆中循环,最后从尿排出。其化学性质稳定是过氧化反应特异的产物,是评价氧化应激和脂质过氧化反应最有效的生物指标。它激活血小板,收缩血管,促进血管平滑肌有丝分裂并引起心肌细胞肥大,在临床心力衰竭的病理生理发展中起了重要作用。TP受体拮抗剂、抗氧化剂及活性氧簇抑制剂能显著减少异构前列腺素的合成及延缓心力衰竭的进展。 Isoprostanes are formed by free radical-catalyzed peroxidation of arachidonic acid. They are released by phospholipase in cellular membrane,circulate in plasma,ultimum and are excreted in urine. Isoprostanes are a specific and chemically stable product of peroxiclarion,so they are the best biological index used to estimate oxidative stress and peroxidation. Isoprostanes can activate platelets, contract blood vessels,promote vascular smooth muscle to caryocinesis and evoke cardiocyte to hypertrophy. They have important effects on the pathophysiology of clinical heart failure. TP receptor antagonist, antioxidant, and ROS catastahica can significantly reduce synthesis of isoprostanes, and delay the progress of heart failure.
出处 《心血管病学进展》 CAS 2007年第2期276-279,共4页 Advances in Cardiovascular Diseases
关键词 异构前列腺素 心力衰竭 氧化应激 相关性 isoprostanes heart failure oxidative stress dependablity
  • 相关文献

参考文献26

  • 1Montuschi P,Barnes PJ.Isoprostanes:markers and mediators of oxidative stress[J].FASEB J,2004,18(15):1791-1800.
  • 2Cracowski JL,Ormezzano O.Isoprostanes,emerging biomarkers and potential mediators in cardiovascular diseases[J].Eur Heart J,2004,25(19):1675-1678.
  • 3Pratico D,Lawson JA,Rokach J.The isoprostanes in biology and medicine[J].Trends Endocrinol Metab,2001,12(6):243-247.
  • 4Stafforini DM,Sheller JR,Blackwell TS,et al.Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases[J].J Biol Chem,2006,281(8):4616-4623.
  • 5Halliwell B.Lipid peroxidation B,antioxidants and cardiovascular disease:how should we move forward[J]? Cardiovasc Res,2000,47(3):410-418.
  • 6Gopaul NK,Zacharowski K,Halliwell B.Evaluation of the postprandial effects of a fast-food meal on human plasma F2-isoprostane levels[J].Free Radic Biol Med,2000,28(5):806-814.
  • 7Roberts LJ,Morrow JD.Measurement of F2-isoprostanes as an index of oxidative stress in vivo[J].Free Radic Biol Med,2000,28(4):505-513.
  • 8Montuschi P.Indirect monitoring of lung inflammation[J].Nat Rev Drug Discov,2002,1(3):238-242.
  • 9Taylor AW,Bruno RS,Frei B.Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F(2)-isoprostanes[J].Anal Biochem,2006,350(1):41-51.
  • 10李绍龙,光雪峰,白文伟.心力衰竭发病机制的研究[J].医学综述,2004,10(12):725-726. 被引量:15

二级参考文献18

  • 1Sakai S, Miyauchi T, Kobayash M, et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure[J]. Nature,1996,384(6607) :353-355.
  • 2Ferguson DW. Sympathetic mechanisms in heart failure: pathophysiological and pharmacological implication[ J]. Circulation, 1993,87 [ Suppl 7] :68.
  • 3Eisenhofer G, Friberg P, Randquist R, et al. Cardiac sympathefic nerve function in congestive heart failure[J]. Circulation, 1996,93(9) : 1667-1676.
  • 4Kabour A, Henegar JR, Janicki JS. Angiotensin Ⅱ (AⅡ) induced myocyte necrosis: role of the AⅡ receptor[J]. J Cardiovasc Pharmacol,1994,23(4) :547-553.
  • 5Sasayama S,Matsumori A. Role of eytokines in the syndrome of heart failure [ J ]. Int Med, 1996,35 ( 1 ) : 60-63.
  • 6Herrera-Garza EH, Stetson SJ, Cubilles-Garzon A, et al Tumor necresis of factor-a:a mediator of disease progession in the failing human heart[J] .Chest, 1999,115(4) : 1170-1174.
  • 7Bradham WS, Moe G, Wendt KA, et al. TNF-alpha and myocardial matrix metalloproteinases in heart failure:relationship to LV remodeling.American journal of physiology [ J ]. Heart Circ Physiol, 2002,282 (4) :1288-1295.
  • 8Torre-Amiore G, Kapadias A, Benedict C, et 02. Proinflammatory cytokine levels in patients with depressed left ventrieular ejection fraction:a report from the studies of left ventricular dysfunction(SOLVD) [ J]. J Am Coil Cardiol,1996,27(5) : 1201-1206.
  • 9Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 ia an important prognostic predictor in patients with congestive heart failure [ J ]. Am Coil Cardiol, 1998,31(2) :391-398.
  • 10Devaux C, Varin R, Mulder P, et al. Oxidative stress and endothelial dysfunction in heart failure[J] .Therapie,2001,56(5) :575-581.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部